切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2019, Vol. 05 ›› Issue (06) : 349 -352. doi: 10.3877/cma.j.issn.2095-9141.2019.06.007

所属专题: 文献

临床研究

高压氧联合奥拉西坦对脑外伤后患者的认知功能及相关细胞因子的影响
王永楠1, 殷杰1, 汤畅通,1   
  1. 1. 221000 徐州市中心医院神经外科(南京医科大学徐州临床医学院)
  • 收稿日期:2019-07-27 出版日期:2019-12-15
  • 通信作者: 汤畅通
  • 基金资助:
    江苏省科技厅临床医学专项课题(BL2014028)

Effects of hyperbaric oxygen combined with Oxiracetam on cognitive function and related cytokines in patients after brain trauma

Yongnan Wang1, Jie Yin1, Changtong Tang,1   

  1. 1. Department of Neurosurgery, Xuzhou Central Hospital (The Xuzhou School of Clinical Medicine of Nanjing Medical University), Xuzhou 221000, China
  • Received:2019-07-27 Published:2019-12-15
  • Corresponding author: Changtong Tang
  • About author:
    Corresponding author: Tang Changtong, Email:
引用本文:

王永楠, 殷杰, 汤畅通. 高压氧联合奥拉西坦对脑外伤后患者的认知功能及相关细胞因子的影响[J/OL]. 中华神经创伤外科电子杂志, 2019, 05(06): 349-352.

Yongnan Wang, Jie Yin, Changtong Tang. Effects of hyperbaric oxygen combined with Oxiracetam on cognitive function and related cytokines in patients after brain trauma[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2019, 05(06): 349-352.

目的

探讨高压氧联合奥拉西坦对外伤后认知障碍患者的认知功能及相关细胞因子的影响。

方法

选取徐州市中心医院神经外科自2017年1月至2018年10月住院治疗的脑外伤后认知障碍的患者60例,随机分为对照组和治疗组各30例,对照组给予传统的常规疗法治疗,治疗组在常规治疗的基础上给予高压氧联合奥拉西坦治疗,疗程3周。治疗前、治疗3周行血清血管形成素-1(Ang-1)、血管内皮生长因子(VEGF)和脑源性神经营养因子(BDNF)浓度测定,采用中文版蒙特利认知评分量表(MOCA)评估认知功能。

结果

2组患者治疗前的血清Ang-1、VEGF、BDNF水平比较,差异无统计学意义(P>0.05)。治疗3周后,2组患者的血清Ang-1、VEGF、BDNF水平均较治疗前增加,治疗组血清Ang-1、VEGF、BDNF水平较对照组增加明显,差异有统计学意义(P<0.05)。2组患者治疗前MOCA评分比较,差异无统计学意义(P>0.05)。治疗3周后,治疗组的MOCA评分较对照组高,差异具有统计学意义(P<0.05)。

结论

高压氧联合奥拉西坦治疗脑外伤后认知障碍患者较常规治疗可促进血清Ang-1、VEGF和BDNF的分泌,从而改善急脑外伤后认知障碍患者的认知功能。

Objective

To investigate the effect of hyperbaric oxygen combined with Oxiracetam on cognitive function and related cytokines in patients with post-traumatic cognitive impairment.

Methods

Sixty patients with post-traumatic cognitive impairment hospitalized from January 2017 to October 2018 in neurosurgery department of Xuzhou Central Hospital were randomly divided into control group and treatment group, 30 cases in each group. The control group received conventional routine treatment, and the treatment group was treated with hyperbaric oxygen combined with Oxiracetam on the basis of routine treatment. The course of treatment is 3 weeks. The concentration of angiopoietin-1 (Ang-1), brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) were measured, and the Chinese version of the Monterey’s cognitive-score scale (MOCA) was used to evaluate the cognitive functions before treatment and 3 weeks after treatment.

Results

Before treatment there was no significant difference in the levels of Ang-1, VEGF and BDNF between the two groups (P>0.05). After 3 weeks of treatment, the serum levels of Ang-1, VEGF and BDNF in the two groups increased. The levels of serum Ang-1, VEGF and BDNF in the treatment group were significantly higher than that in the control group, and the difference was statistically significant (P<0.05). There was no significant difference in MOCA score between the two groups before treatment (P>0.05). After 3 weeks of treatment, the MOCA score of the treatment group was higher than that of the control group (P<0.05), and the difference was statistically significant.

Conclusion

Compared with conventional therapy, hyperbaric oxygen combined with oxiracetam can promote the secretion of Ang-1, VEGF and BDNF in patients with post-traumatic cognitive impairment, thus improving the cognitive function of patients with post-traumatic cognitive impairment.

表1 2组患者的基本资料
表2 2组患者治疗前后血清Ang-1、VEGF、BDNF水平比较
表3 2组患者治疗前后的MOCA评分比较(±s
[1]
Thomas AG, Hegde SV, Dineen RA, et al. Patterns of accidental craniocerebral injury occurring in early childhood[J]. Arch Dis Childhood, 2013, 98(10): 787-792.
[2]
Arciniegas DB, Held K, Wagner P. Cognitive impairment following traumatic brain injury[J]. Curr Treat Options Neurol, 2002, 4(1): 43-57.
[3]
Foster M, Spiegel DR. Use of donepezil in the treatment of cognitive impairments of moderate traumatic brain injury[J]. J Neuropsychiatry Clin Neurosci, 2008, 20(1): 106.
[4]
Finnanger TG, Skandsen T, Andersson S, et al. Differentiated patterns of cognitive impairment 12 months after severe and moderate traumatic brain injury[J]. Brain Inj, 2013, 27(13-14): 1606-1616.
[5]
Du J, Yin J, Liu L, et al. Clinical observation of 60 cases of treating cognitive disorder after cerebral injury in combination with scalp acupuncture and cognitive training[J]. Medicine, 2018, 97(40): e12420.
[6]
Gallagher M, McLeod HJ, McMillan TM. A systematic review of recommended modifications of CBT for people with cognitive impairments following brain injury[J]. Neuropsychol Rehabil, 2019, 29(1): 1-21.
[7]
Li W, Liu H, Jiang H, et al. (S)-Oxiracetam is the active ingredient in oxiracetam that alleviates the cognitive impairment induced by chronic cerebral hypoperfusion in rats[J]. Sci Rep, 2017, 7(1): 10052.
[8]
施丽琴,杨文进,方琴,等.奥拉西坦联合高压氧治疗脑外伤综合征的疗效分析[J].临床医学研究与实践, 2018, 3(4): 33-34.
[9]
Koester-Hegmann C, Bengoetxea H, Kosenkov D, et al. High-altitude cognitive impairment is prevented by enriched environment including exercise via VEGF signaling[J]. Front Cell Neurosci, 2018, 12: 532.
[10]
葛权虎,吴向未,程文哲,等.小鼠骨髓间充质干细胞对血管内皮祖细胞分化潜能的影响[J].山东医药, 2017, 57(28): 12-15.
[11]
白蓉,梁雪琴,王魁花.康复训练对脑缺血大鼠行为学及BDNF、CaBP-D28k表达的影响[J].山东医药, 2012, 52(21): 33-35.
[12]
周华,王锋,沈蓉,等.血浆IL-17A与脑白质病变及血管性认知障碍的相关性研究[J].中国实用神经疾病杂志, 2019, 22(1): 6-11.
[13]
Soeda A, Nakashima T, Okumura A, et al. Cognitive impairment after traumatic brain injury: a functional magnetic resonance imaging study using the Stroop task[J]. Neuroradiology, 2005, 47(7): 501-506.
[14]
米小昆,史健,刘辉,等.电刺激小脑顶核和奥拉西坦及尼莫地平对卒中后非痴呆性认知障碍患者不同认知领域的影响研究[J].中国全科医学, 2019, 22(11): 1293-1297.
[15]
Daly S, Thorpe M, Rockswold S, et al. Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review[J]. J Neurotrauma, 2018, 35(4): 623-629.
[16]
Hsu SL, Yin TC, Shao PL, et al. Hyperbaric oxygen facilitates the effect of endothelial progenitor cell therapy on improving outcome of rat critical limb ischemia[J]. Am J Transl Res, 2019, 11(4): 1948.
[17]
Tan JW, Zhang F, Liu HJ, et al. Hyperbaric oxygen ameliorated the lesion scope and nerve function in acute spinal cord injury patients: a retrospective study[J]. Clin Biochem, 2018, 53: 1-7.
[18]
Yan M, Hu Y, Yao M, et al. GM-CSF ameliorates microvascular barrier integrity via pericyte-derived Ang-1 in wound healing[J]. Wound Repair Regen, 2017, 25(6): 933-943.
[19]
Skóra JP, Płonek T, Barć P, et al. The formation of blood vessel after the administration of the plasmid encoding ang-1 gene in fischer rats[J]. Adv Clin Exp Med, 2016, 25(4): 611-615.
[20]
Marks ECA, Wilkinson TM, Frampton CM, et al. Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes[J]. BMC Cardiovasc Disord, 2018, 18(1): 169.
[21]
Baydyuk M, Xu B. BDNF signaling and survival of striatal neurons[J]. Front Cell Neurosci, 2014, 8(2): 254.
[22]
Rothman SM, Griffioen KJ, Wan R, et al. Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health[J]. Ann N Y Acad Sci, 2012, 1264(1): 49-63.
[1] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[2] 李英纳, 李敏, 周澳洋, 李平, 杨凡. 肥胖症儿童血浆脑源性神经营养因子水平及其代谢异常的相关性研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 81-88.
[3] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[4] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
[5] 张敏龙, 杨翠平, 王博, 崔云杰, 金发光. MiR-200b-3p 通过抑制HIF-1α 表达减轻海水吸入诱导的肺水肿作用及机制[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 696-700.
[6] 庞丹, 孙刚, 伊乐, 丁立云, 钟美艳, 张杰, 于婷婷, 郭乐峰. 血清HIF-1α、VEGF、Flt-1的检测对ARDS的预后及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 127-130.
[7] 暴静, 吴霞, 田雅萍, 尹钢. 维生素D3联合孟鲁司特钠治疗支气管哮喘对血清VEGF、TGF-β1及肺功能的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 63-67.
[8] 朱迎, 赵征, 许达, 陆录, 殷保兵. 免疫检查点抑制剂治疗肝细胞癌的进展与展望[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 5-10.
[9] 杨金涓, 夏建平. 糖尿病性黄斑水肿患者基线房水细胞因子水平评估血管内皮生长因子疗效的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 350-355.
[10] 刘涵, 沈强, 张蓝月, 陈健. 糖尿病视网膜病变分子生物标志物的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 376-380.
[11] 胡贤瑞, 伍振国, 何竟. 高压氧治疗创伤性脑损伤患者认知功能障碍疗效的Meta分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 21-36.
[12] 邸志娟, 李红玲. HBOT在创伤性脑损伤患者中的应用及研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 373-378.
[13] 宋建波, 韩俊伟, 周敏, 温红萍. 血管内皮生长因子受体酪氨酸激酶抑制剂致蛋白尿风险的荟萃分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(12): 1297-1303.
[14] 田桦, 丁芳, 黄晓莉, 张丽君. 脑蛋白水解物对痉挛型脑瘫患儿肌肉痉挛评分、脑血流量及血清IGF-1、MBP、IL-6的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 49-54.
[15] 巩江华, 李凝香, 李坚, 李枫, 童莉, 邢宏利, 何新霞. 探讨原发性高血压伴失眠患者血清NPY、5-HT、BDNF水平变化及其临床意义[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(06): 582-590.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
50
最新录用 在线预览 正式出版
0 0 50
  来源 本网站 其他网站
  次数 27 24
  比例 53% 47%